Sensitive electrochemical biosensor combined with isothermal amplification for point-of-care COVID-19 tests

Biosens Bioelectron. 2021 Jun 15:182:113168. doi: 10.1016/j.bios.2021.113168. Epub 2021 Mar 18.

Abstract

We report an electrochemical biosensor combined with recombinase polymerase amplification (RPA) for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2. The electrochemical biosensor based on a multi-microelectrode array allows the detection of multiple target genes by differential pulse voltammetry. The RPA reaction involves hybridization of the RPA amplicon with thiol-modified primers immobilized on the working electrodes, which leads to a reduction of current density as amplicons accumulate. The assay results in shorter "sample-to-answer" times than conventional PCR without expensive thermo-cycling equipment. The limits of detection are about 0.972 fg/μL (RdRP gene) and 3.925 fg/μL (N gene), which are slightly lower than or comparable to that of RPA assay results obtained by gel electrophoresis without post-amplification purification. The combination of electrochemical biosensors and the RPA assay is a rapid, sensitive, and convenient platform that can be potentially used as a point-of-care test for the diagnosis of COVID-19.

Keywords: COVID-19; Coronavirus; Electrochemical detection method; Recombinase polymerase amplification; SARS-CoV-2.

MeSH terms

  • Biosensing Techniques*
  • COVID-19 / diagnosis*
  • Humans
  • Nucleic Acid Amplification Techniques*
  • Point-of-Care Testing*
  • SARS-CoV-2 / isolation & purification
  • Sensitivity and Specificity